Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinoblastoma | 38 | 2021 | 321 | 9.890 |
Why?
|
Retina | 45 | 2022 | 2661 | 5.250 |
Why?
|
Retinal Neoplasms | 20 | 2016 | 151 | 5.080 |
Why?
|
Retinoblastoma Protein | 20 | 2021 | 673 | 3.220 |
Why?
|
Neuroblastoma | 16 | 2022 | 1266 | 3.150 |
Why?
|
Stem Cells | 22 | 2022 | 3540 | 1.850 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 9 | 2016 | 362 | 1.420 |
Why?
|
Gene Expression Regulation, Developmental | 17 | 2022 | 3613 | 1.320 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 3 | 2020 | 306 | 1.310 |
Why?
|
Nuclear Proteins | 19 | 2018 | 5803 | 1.300 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2020 | 3621 | 1.220 |
Why?
|
Cell Differentiation | 29 | 2022 | 11684 | 1.150 |
Why?
|
Rhabdomyosarcoma | 5 | 2022 | 358 | 1.140 |
Why?
|
Retinal Rod Photoreceptor Cells | 6 | 2019 | 204 | 1.120 |
Why?
|
Disease Models, Animal | 24 | 2020 | 18366 | 0.940 |
Why?
|
DNA Helicases | 6 | 2016 | 854 | 0.920 |
Why?
|
Retinal Bipolar Cells | 3 | 2020 | 46 | 0.900 |
Why?
|
Organoids | 2 | 2021 | 745 | 0.870 |
Why?
|
Rhabdomyosarcoma, Embryonal | 2 | 2022 | 99 | 0.850 |
Why?
|
Killer Cells, Natural | 4 | 2020 | 2211 | 0.830 |
Why?
|
Osteosarcoma | 6 | 2019 | 911 | 0.830 |
Why?
|
Mice | 74 | 2022 | 82074 | 0.790 |
Why?
|
Genes, Retinoblastoma | 5 | 2015 | 125 | 0.780 |
Why?
|
Epigenesis, Genetic | 11 | 2021 | 3836 | 0.770 |
Why?
|
Neurogenesis | 3 | 2022 | 865 | 0.760 |
Why?
|
Animals | 97 | 2022 | 169408 | 0.750 |
Why?
|
Regulatory Sequences, Nucleic Acid | 4 | 2022 | 792 | 0.740 |
Why?
|
Gangliosides | 2 | 2019 | 132 | 0.720 |
Why?
|
Tumor Suppressor Protein p53 | 14 | 2016 | 2960 | 0.710 |
Why?
|
Epigenomics | 6 | 2022 | 961 | 0.700 |
Why?
|
Cell Cycle | 12 | 2015 | 2937 | 0.700 |
Why?
|
Euchromatin | 1 | 2019 | 54 | 0.670 |
Why?
|
Neoplasms | 18 | 2023 | 22390 | 0.660 |
Why?
|
Cell Division | 12 | 2007 | 4478 | 0.640 |
Why?
|
Eye | 5 | 2014 | 712 | 0.630 |
Why?
|
Interleukin-15 | 1 | 2019 | 186 | 0.620 |
Why?
|
Retinal Degeneration | 4 | 2022 | 414 | 0.610 |
Why?
|
Topotecan | 2 | 2010 | 131 | 0.600 |
Why?
|
Synapses | 5 | 2020 | 1766 | 0.590 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2021 | 8664 | 0.580 |
Why?
|
Homeodomain Proteins | 8 | 2022 | 2431 | 0.560 |
Why?
|
Heterochromatin | 1 | 2019 | 294 | 0.550 |
Why?
|
Mental Retardation, X-Linked | 1 | 2017 | 42 | 0.550 |
Why?
|
alpha-Thalassemia | 1 | 2017 | 53 | 0.550 |
Why?
|
Proto-Oncogene Proteins | 7 | 2017 | 4528 | 0.550 |
Why?
|
Genes, Tumor Suppressor | 5 | 2016 | 1064 | 0.540 |
Why?
|
Imidazoles | 6 | 2017 | 1169 | 0.540 |
Why?
|
Cell Proliferation | 15 | 2022 | 10486 | 0.540 |
Why?
|
Organogenesis | 1 | 2018 | 214 | 0.540 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2015 | 2848 | 0.540 |
Why?
|
Bone Neoplasms | 6 | 2019 | 2565 | 0.530 |
Why?
|
Molecular Targeted Therapy | 5 | 2018 | 2830 | 0.530 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2018 | 2433 | 0.520 |
Why?
|
Laryngeal Neoplasms | 4 | 2021 | 514 | 0.520 |
Why?
|
Genomics | 12 | 2021 | 5928 | 0.500 |
Why?
|
Neurons | 10 | 2022 | 9524 | 0.500 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2017 | 633 | 0.500 |
Why?
|
Cell Line, Tumor | 23 | 2022 | 17174 | 0.500 |
Why?
|
Antineoplastic Agents | 13 | 2021 | 13699 | 0.500 |
Why?
|
Genetic Engineering | 4 | 2015 | 936 | 0.490 |
Why?
|
Histones | 5 | 2019 | 2603 | 0.480 |
Why?
|
Retinal Ganglion Cells | 4 | 2022 | 811 | 0.480 |
Why?
|
Cell Cycle Proteins | 12 | 2018 | 3450 | 0.480 |
Why?
|
Immunotherapy | 4 | 2020 | 4755 | 0.460 |
Why?
|
Radiosurgery | 4 | 2021 | 1346 | 0.460 |
Why?
|
Mice, Knockout | 20 | 2022 | 14485 | 0.450 |
Why?
|
Piperazines | 7 | 2017 | 2553 | 0.450 |
Why?
|
Mice, Transgenic | 12 | 2022 | 9564 | 0.430 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 288 | 0.430 |
Why?
|
Cell Lineage | 9 | 2022 | 2576 | 0.420 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3554 | 0.420 |
Why?
|
Chromatin | 6 | 2019 | 2981 | 0.410 |
Why?
|
Cell Death | 7 | 2014 | 1682 | 0.410 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2021 | 812 | 0.410 |
Why?
|
Retinal Horizontal Cells | 1 | 2011 | 10 | 0.400 |
Why?
|
Acetates | 2 | 2012 | 317 | 0.390 |
Why?
|
Oxazines | 1 | 2014 | 358 | 0.390 |
Why?
|
DNA Methylation | 4 | 2021 | 4432 | 0.390 |
Why?
|
Protein Kinase Inhibitors | 5 | 2019 | 5707 | 0.380 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9264 | 0.380 |
Why?
|
Humans | 126 | 2023 | 768887 | 0.380 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2021 | 1891 | 0.380 |
Why?
|
Dendrites | 2 | 2011 | 472 | 0.370 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2011 | 94 | 0.370 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2018 | 11886 | 0.370 |
Why?
|
Radiation Oncology | 3 | 2021 | 572 | 0.350 |
Why?
|
Sympathetic Nervous System | 1 | 2013 | 521 | 0.350 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2016 | 2892 | 0.350 |
Why?
|
Body Patterning | 3 | 2015 | 634 | 0.340 |
Why?
|
Globins | 5 | 1998 | 405 | 0.340 |
Why?
|
Melphalan | 1 | 2011 | 421 | 0.340 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1966 | 0.340 |
Why?
|
High-Throughput Screening Assays | 4 | 2018 | 941 | 0.340 |
Why?
|
Oncogene Proteins | 1 | 2014 | 718 | 0.340 |
Why?
|
Cebus | 1 | 2009 | 15 | 0.330 |
Why?
|
Carboplatin | 2 | 2010 | 799 | 0.330 |
Why?
|
Interneurons | 2 | 2007 | 593 | 0.330 |
Why?
|
RNA Splicing | 2 | 2022 | 905 | 0.330 |
Why?
|
Aotidae | 1 | 2009 | 57 | 0.330 |
Why?
|
Retroviridae | 3 | 2007 | 849 | 0.330 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3421 | 0.320 |
Why?
|
Nervous System Neoplasms | 2 | 2011 | 91 | 0.320 |
Why?
|
Pigmentation | 1 | 2009 | 143 | 0.310 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2017 | 2911 | 0.310 |
Why?
|
Transcription Factors | 8 | 2022 | 12174 | 0.310 |
Why?
|
Ciliary Body | 1 | 2009 | 168 | 0.300 |
Why?
|
Biological Evolution | 3 | 2016 | 1078 | 0.300 |
Why?
|
Tissue Culture Techniques | 2 | 2006 | 290 | 0.300 |
Why?
|
Medical Oncology | 2 | 2020 | 2350 | 0.300 |
Why?
|
Galantamine | 1 | 2008 | 33 | 0.300 |
Why?
|
Child | 29 | 2022 | 80969 | 0.300 |
Why?
|
Gene Silencing | 3 | 2014 | 1505 | 0.290 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2011 | 618 | 0.290 |
Why?
|
Laryngectomy | 2 | 2020 | 245 | 0.290 |
Why?
|
Genes, myc | 2 | 2011 | 391 | 0.290 |
Why?
|
Mice, Inbred C57BL | 19 | 2022 | 22381 | 0.290 |
Why?
|
Chromosome Aberrations | 2 | 2014 | 1780 | 0.290 |
Why?
|
Retinoblastoma-Like Protein p107 | 4 | 2009 | 71 | 0.280 |
Why?
|
Pyrazoles | 3 | 2017 | 2029 | 0.280 |
Why?
|
Interferon-beta | 1 | 2009 | 349 | 0.280 |
Why?
|
Gene Amplification | 4 | 2020 | 1099 | 0.280 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 5 | 2008 | 317 | 0.270 |
Why?
|
Tumor Suppressor Proteins | 5 | 2009 | 2813 | 0.270 |
Why?
|
Neural Crest | 2 | 2022 | 278 | 0.260 |
Why?
|
Cholinesterase Inhibitors | 1 | 2008 | 241 | 0.260 |
Why?
|
Optic Nerve | 1 | 2009 | 571 | 0.260 |
Why?
|
Anus Neoplasms | 2 | 2021 | 336 | 0.260 |
Why?
|
Microtubule-Associated Proteins | 2 | 2001 | 1073 | 0.250 |
Why?
|
Mutation | 19 | 2021 | 30266 | 0.250 |
Why?
|
Neuroglia | 2 | 2022 | 960 | 0.240 |
Why?
|
Cell Nucleus | 6 | 2020 | 2885 | 0.240 |
Why?
|
DNA Repair | 1 | 2014 | 2054 | 0.240 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2004 | 50 | 0.240 |
Why?
|
Radiotherapy Dosage | 7 | 2023 | 2920 | 0.240 |
Why?
|
Combined Modality Therapy | 4 | 2023 | 8559 | 0.240 |
Why?
|
Genetics | 1 | 2005 | 114 | 0.240 |
Why?
|
Brachytherapy | 2 | 2023 | 1224 | 0.240 |
Why?
|
Electroporation | 1 | 2006 | 238 | 0.240 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4919 | 0.230 |
Why?
|
Cyclins | 3 | 2003 | 606 | 0.230 |
Why?
|
RNA, Messenger | 4 | 2014 | 12809 | 0.230 |
Why?
|
Clinical Protocols | 1 | 2010 | 1445 | 0.230 |
Why?
|
Genetic Vectors | 3 | 2009 | 3414 | 0.230 |
Why?
|
Gene Transfer Techniques | 1 | 2009 | 1209 | 0.220 |
Why?
|
Dependovirus | 1 | 2009 | 721 | 0.220 |
Why?
|
Cell Line | 9 | 2021 | 15603 | 0.220 |
Why?
|
Biomedical Research | 3 | 2020 | 3463 | 0.220 |
Why?
|
Mice, Mutant Strains | 3 | 2007 | 1755 | 0.220 |
Why?
|
Neoplasm Staging | 9 | 2023 | 11262 | 0.210 |
Why?
|
Age of Onset | 2 | 2012 | 3346 | 0.210 |
Why?
|
Gene Expression Profiling | 9 | 2022 | 9549 | 0.210 |
Why?
|
Exons | 2 | 2021 | 2395 | 0.210 |
Why?
|
Brain Neoplasms | 3 | 2014 | 9213 | 0.210 |
Why?
|
Pediatrics | 2 | 2015 | 3628 | 0.210 |
Why?
|
Camptothecin | 2 | 2017 | 600 | 0.200 |
Why?
|
Adrenergic Agents | 1 | 2022 | 73 | 0.200 |
Why?
|
Pyridines | 1 | 2014 | 2896 | 0.200 |
Why?
|
Eye Proteins | 6 | 2014 | 628 | 0.200 |
Why?
|
Enhancer Elements, Genetic | 2 | 2019 | 1369 | 0.190 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 4 | 2003 | 43 | 0.190 |
Why?
|
Female | 44 | 2023 | 397464 | 0.190 |
Why?
|
Interleukin-2 | 2 | 2019 | 1895 | 0.190 |
Why?
|
Melanoma | 3 | 2015 | 5709 | 0.190 |
Why?
|
Indoles | 2 | 2021 | 1836 | 0.190 |
Why?
|
Apoptosis | 4 | 2015 | 9528 | 0.190 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2021 | 121 | 0.180 |
Why?
|
Mice, Nude | 5 | 2021 | 3631 | 0.180 |
Why?
|
Species Specificity | 3 | 2013 | 2419 | 0.180 |
Why?
|
Glutamic Acid | 1 | 2006 | 1193 | 0.180 |
Why?
|
DNA Copy Number Variations | 4 | 2021 | 2055 | 0.180 |
Why?
|
Muscle Development | 1 | 2022 | 258 | 0.170 |
Why?
|
Mice, Inbred ICR | 4 | 2001 | 363 | 0.170 |
Why?
|
Vincristine | 2 | 2017 | 1040 | 0.170 |
Why?
|
Rats | 9 | 2010 | 23847 | 0.170 |
Why?
|
Neoplasm Transplantation | 3 | 2015 | 2018 | 0.170 |
Why?
|
Amacrine Cells | 1 | 2020 | 52 | 0.170 |
Why?
|
Mice, SCID | 2 | 2018 | 2631 | 0.170 |
Why?
|
Small Molecule Libraries | 3 | 2019 | 742 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 6 | 2009 | 8200 | 0.170 |
Why?
|
Drug Synergism | 3 | 2021 | 1762 | 0.170 |
Why?
|
Repressor Proteins | 4 | 2019 | 2986 | 0.170 |
Why?
|
Promoter Regions, Genetic | 5 | 2019 | 5801 | 0.170 |
Why?
|
Tumor Cells, Cultured | 5 | 2020 | 6131 | 0.170 |
Why?
|
Tumor Burden | 2 | 2018 | 1913 | 0.170 |
Why?
|
Nuclear Lamina | 1 | 2019 | 46 | 0.170 |
Why?
|
Gliosis | 1 | 2000 | 246 | 0.170 |
Why?
|
Prisoners | 1 | 2023 | 316 | 0.160 |
Why?
|
Cell Culture Techniques | 2 | 2018 | 1667 | 0.160 |
Why?
|
Vision, Ocular | 1 | 2022 | 458 | 0.160 |
Why?
|
Glottis | 1 | 2020 | 214 | 0.160 |
Why?
|
Telomere | 2 | 2017 | 943 | 0.160 |
Why?
|
Transgenes | 2 | 2015 | 1016 | 0.160 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.150 |
Why?
|
Morpholines | 1 | 2021 | 584 | 0.150 |
Why?
|
Genome, Human | 5 | 2021 | 4456 | 0.150 |
Why?
|
Single-Cell Analysis | 2 | 2020 | 2542 | 0.150 |
Why?
|
DEAD-box RNA Helicases | 2 | 2012 | 385 | 0.150 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5864 | 0.150 |
Why?
|
Models, Biological | 6 | 2012 | 9499 | 0.150 |
Why?
|
Drug Discovery | 2 | 2016 | 1068 | 0.150 |
Why?
|
Central Nervous System | 1 | 2005 | 1345 | 0.150 |
Why?
|
High Mobility Group Proteins | 1 | 1998 | 179 | 0.140 |
Why?
|
Co-Repressor Proteins | 2 | 2017 | 190 | 0.140 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 538 | 0.140 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2714 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 329 | 0.140 |
Why?
|
Erythroid Precursor Cells | 1 | 1998 | 212 | 0.140 |
Why?
|
Regenerative Medicine | 2 | 2022 | 311 | 0.140 |
Why?
|
Embryonic Stem Cells | 2 | 2015 | 1251 | 0.140 |
Why?
|
Sequence Analysis, DNA | 6 | 2015 | 4784 | 0.140 |
Why?
|
Pyrimidines | 2 | 2021 | 3050 | 0.140 |
Why?
|
Glycine | 1 | 2001 | 672 | 0.140 |
Why?
|
Muscle Neoplasms | 1 | 2018 | 130 | 0.140 |
Why?
|
Rhabdoid Tumor | 1 | 2019 | 211 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2014 | 16051 | 0.140 |
Why?
|
Conjunctiva | 2 | 2011 | 475 | 0.140 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 2023 | 1679 | 0.140 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6320 | 0.140 |
Why?
|
Disease Progression | 6 | 2014 | 13677 | 0.140 |
Why?
|
Intraocular Pressure | 2 | 2015 | 1304 | 0.140 |
Why?
|
Epithelial Cells | 1 | 2009 | 3701 | 0.140 |
Why?
|
Transcriptional Elongation Factors | 1 | 1998 | 169 | 0.140 |
Why?
|
Carrier Proteins | 3 | 2004 | 4940 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10778 | 0.130 |
Why?
|
Drug Repositioning | 1 | 2018 | 245 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6546 | 0.130 |
Why?
|
Antigen Presentation | 1 | 2022 | 1252 | 0.130 |
Why?
|
Cell Adhesion | 2 | 2015 | 3102 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2018 | 778 | 0.130 |
Why?
|
Histone Code | 1 | 2017 | 160 | 0.130 |
Why?
|
Drug Resistance | 1 | 2022 | 1600 | 0.130 |
Why?
|
Tretinoin | 2 | 2018 | 525 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2063 | 0.130 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 892 | 0.130 |
Why?
|
Adult | 21 | 2021 | 223818 | 0.130 |
Why?
|
Nerve Tissue Proteins | 3 | 2003 | 4415 | 0.130 |
Why?
|
Neuropsychological Tests | 2 | 2008 | 7148 | 0.130 |
Why?
|
Tumor Virus Infections | 1 | 2018 | 437 | 0.130 |
Why?
|
Male | 33 | 2023 | 365249 | 0.130 |
Why?
|
Microphthalmos | 1 | 2015 | 58 | 0.120 |
Why?
|
Blood Vessels | 1 | 2001 | 1110 | 0.120 |
Why?
|
Neural Pathways | 1 | 2006 | 3120 | 0.120 |
Why?
|
Antipsychotic Agents | 2 | 2008 | 3081 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4064 | 0.120 |
Why?
|
E2F3 Transcription Factor | 1 | 2014 | 36 | 0.120 |
Why?
|
Loss of Heterozygosity | 3 | 2015 | 663 | 0.120 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 859 | 0.120 |
Why?
|
Pyrimidinones | 1 | 2017 | 386 | 0.120 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2016 | 701 | 0.120 |
Why?
|
Hepatoblastoma | 1 | 2015 | 90 | 0.120 |
Why?
|
Hydroxamic Acids | 1 | 2017 | 483 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2022 | 2001 | 0.120 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 182 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2001 | 1143 | 0.120 |
Why?
|
Base Sequence | 11 | 2019 | 12430 | 0.110 |
Why?
|
Adrenocortical Carcinoma | 1 | 2015 | 88 | 0.110 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1839 | 0.110 |
Why?
|
Paired Box Transcription Factors | 1 | 2014 | 206 | 0.110 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 183 | 0.110 |
Why?
|
Haplorhini | 2 | 2006 | 524 | 0.110 |
Why?
|
Survival Rate | 6 | 2021 | 12873 | 0.110 |
Why?
|
Clone Cells | 1 | 2017 | 1670 | 0.110 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2015 | 411 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2008 | 3985 | 0.110 |
Why?
|
Embryo, Mammalian | 5 | 2006 | 1676 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2022 | 1602 | 0.110 |
Why?
|
DNA, Neoplasm | 3 | 2014 | 1748 | 0.110 |
Why?
|
Neoplasms, Experimental | 2 | 2010 | 1231 | 0.110 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2015 | 419 | 0.110 |
Why?
|
DNA Primers | 2 | 2012 | 2827 | 0.110 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2015 | 161 | 0.110 |
Why?
|
Child, Preschool | 10 | 2021 | 42684 | 0.110 |
Why?
|
Ribonuclease III | 2 | 2012 | 271 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11119 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2015 | 371 | 0.110 |
Why?
|
Sialoglycoproteins | 1 | 2014 | 320 | 0.100 |
Why?
|
|